Neuropsychopharmacology - Figure 2 for article: Cannabinoid Receptor Antagonists Counteract Sensorimotor Gating Deficits in the Phencyclidine Model of Psychosis

FROM:

Cannabinoid Receptor Antagonists Counteract Sensorimotor Gating Deficits in the Phencyclidine Model of Psychosis

Martina Ballmaier, Marco Bortolato, Cristina Rizzetti, Michele Zoli, GianLuigi Gessa, Andreas Heinz and PierFranco Spano

BACK TO ARTICLE

Figure 2.

Next figurePrevious figureFigure and tables index

Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

(a) Effects of rimonabant (0.75–3.0 mg/kg, s.c.) on disruption of PPI induced by phencyclidine (1.25 mg/kg, s.c.). (b) Effects of rimonabant (0.75–3.0 mg/kg, s.c.) and/or phencyclidine (1.25 mg/kg, s.c.) on startle amplitude. PCP=phencyclidine.

Next figurePrevious figureFigure and tables index

BACK TO ARTICLE

FIGURE 2

Cannabinoid Receptor Antagonists Counteract Sensorimotor Gating Deficits in the Phencyclidine Model of Psychosis

Figure 2.